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Abstract According to the leading theory, the agent responsible 
for prion diseases would be the conformational isomer PrPSc of a 
cellular protein PrPc , the pathogenic form PrPSc multiplying by 
converting the normal protein into a likeness of itself. The 
pathogenic isoform could catalyze the conformational transition 
so that the process, taken as a whole, is autocatalytic. However, 
in this simple but atypic model, unrealistic values of rate 
parameters are needed in order to account for the kinetics of the 
propagation of prion diseases. In this paper, I show that these 
limits can be overcome by assuming that catalysis proceeds 
through a multimeric assembly of the pathogenic isoform of the 
prion protein. Such a structure would indeed be able to provide 
cooperativity both at the assembly and conformational change 
levels, strongly reinforcing the autocatalytic character of the 
activated process. Moreover, such a property is a prerequisite to 
endow the metabolic system with dynamic bistability. Together 
with a good agreement regarding experimental data, this analysis 
is closely akin to Griffith's original idea concerning the 
fhermodynamic conditions required for autocatalyzed modifica-
tions of any protein. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Compelling evidence [1^1] strongly suggests that a post-
translational structural alteration in a glycoprotein PrP c 
(the normal, cellular isoform of the so-called prion protein) 
is responsible for pathogenesis of transmissible spongiform 
encephalopathies (or prion diseases). No chemical difference 
has been detected so far between PrP c and PrPSc, the modi-
fied, pathogenic form of the protein. On the other hand, the 
two forms differ in their physicochemical properties and in 
their secondary structure [5-7]. Moreover, Bessen et al. [8] 
took advantage that two hamster-adapted mink strains give 
rise to two distinguishable PrPSc molecular species to show 
that, in a cell-free system, PrPSc from the two strains can 
convert the same PrP c protein into two distinct sets of prod-
ucts that have the same physicochemical properties than those 
of natural PrPSc molecules associated with the two strains. 
These data support the idea that PrP c and PrPSc are confor-
mational isomers and that the pathogen isoform PrPSc may 
impose its conformation upon the native protein PrP c . 
Whereas Griffith [9] first suggested that there are no ther-
modynamic reasons preventing the self-replication of proteins, 
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Prusiner's group provided much experimental evidence in fa-
vor of the 'protein only' hypothesis. Moreover, Prusiner first 
proposed a molecular mechanism for an autocatalytic turn-
over of the host protein into its pathologic isoform [1]. In the 
corresponding model, the constitutive PrP c protein would be 
unfolded to some extent and subsequently refolded under the 
influence of PrPSc molecules. As a derivative, Liautard sug-
gested that prions could be misfolded molecular chaperones 
[10]. This globally autocatalytic process requires the presence 
of preexisting PrPSc which is supposed to be formed very 
slowly by spontaneous conversion. Inherited prion diseases 
are linked to one of a number of mutations in the PrP gene 
which are assumed to increase the frequency of the sponta-
neous conversion of PrP c into PrPSc. 
However, Eigen recently argued [11] that quite unrealistic 
values of rate parameters are needed in order to allow such a 
process to occur. The mechanism has to navigate between an 
extremely low value of the first-order rate constant (ks) of 
spontaneous conversion (otherwise pathogenic form will 
grow spontaneously even without infection) and a rather 
high value of the catalytic constant {kcsA) of the activated 
process of conformational change (otherwise the mechanism 
could never become effective, even in the presence of infec-
tion). According to Eigen, the catalytic enhancement (being 
expressed by the ratio kCKJks) has to be larger than 1015. We 
are not aware of any non-cooperative enzymatic turnover 
which realizes such a rate enhancement. 
Alternatively, I recently suggested [12,13] that the infective 
mechanism of prion diseases does not necessarily need to be 
viewed as an explosive mechanism (i.e. a non-equilibrium 
mechanism in which infection only accelerates a process which 
is otherwise too slow to become fatal during the normal life-
time of the organism). Assuming only a positive feedback 
loop in the catalyzed conversion between PrP c and PrPSc iso-
forms of the protein, we can show that the metabolic system 
which involves the prion protein possesses bistability proper-
ties. Hence, infection would correspond to a switch between 
two alternative stable steady-states. Convergent and similar 
theoretical analysis was performed simultaneously by Kacser 
and Small [14]. 
Hence, a possible cooperative mechanism of conversion be-
tween PrPc and PrPSc would not only be much more realistic 
with regard to catalytic prerequisites but be also of a great 
interest for the understanding of the dynamic of prion inva-
sion. Experimental data [15] supports the contention that 
PrPSc could act as a multimeric assembly in the catalytic 
process. In this paper, I derive the thermodynamic require-
ments allowing a cooperative conformational change of prion 
protein to occur and show how such a process would enhance 
the autocatalytic effect compared to the simple mechanism of 
Prusiner. 
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2. Results 
Whatever the molecular mechanism of the catalyzed con-
version between PrP c and PrPSc isoforms of the prion protein, 
the product of the reaction (the PrPSc isoform) is also part of 
the catalyst (or the catalyst itself in the mechanism of 
Prusiner). This characteristic provides an autocatalytic en-
hancement of the conversion rate. However, in the unimolec-
ular mechanism of catalysis, amplification is linear because 
the velocity increases proportionally to the concentration of 
the product of the reaction (without any modification of the 
rate constant). Although conformational change looks like 
some aspects of the induced-fit hypothesis (which plays an 
important role in the cooperative properties of allosteric en-
zymes), no cooperative effect may be expected in such a model 
in which the catalyst is a monomer. A quite different situation 
prevails if we supposed that any oligomeric form of PrPSc can 
act as a catalyst. 
The concepts of enzyme cooperativity and allostery have 
been formulated 30 years ago [16-18]. However, the mecha-
nism of conversion between PrP c and PrPSc isoforms of the 
prion protein presents unusual and interesting characteristics, 
since the concentration of the catalyst increases as the reaction 
progresses. Fig. 1 shows the global scheme corresponding to 
the case in which both monomeric and dimeric forms of PrPSc 
can convert the normal isoform PrP c of the prion protein. 
Two possible pathways for achieving conformational changes 
may be considered: (1) an initial conversion of the first PrP c 
subunit bound to the PrPSc isoform followed by the binding 
of the second PrP c subunit to the changed p rpSc-PrPSc qua-
ternary structure; (2) an initial binding of the two PrP c sub-
units to the PrPSc isoform followed by a sequential conforma-
tional change. Thermodynamic considerations require that 
any pathway must give the same over-all equilibrium con-
stant. Hence, without assuming that the corresponding direc-
tion is dominant, we shall analyse pathway 2 with the aim to 
clearly set apart binding steps from conformational transi-
tions. 
change in one PrP c subunit can affect stability and/or con-
formation of neighboring subunits? Such a question directly 
pertains to the allosteric concept. The answer is quite simple if 
we assume that the region enclosing the complementary bond-
ing sets of two monomers through which they are linked (i.e. 
the domain of bonding) is made up of two different binding 
sets (i.e. the associations between subunits are heterologous). 
On the other hand, if we suppose that the domain of bonding 
involves two identical bonding sets (isologous associations), 
infinite helical structure would be expected [22]. We shall de-
fine the following ideal energy contributions: 
2.1. Cooperativity at the assembly stage 
In a classical allosteric system in which the ligand is a small 
molecule, intrinsic binding steps are never cooperative by 
themselves [16-20]. The situation may be quite different for 
the prion protein since the size of the ligand (PrPc) compares 
with that of the catalyst (PrPSc or PrPSc-PrPSc). The over-all 
assembly stage corresponds to two consecutive binding proc-
esses having distinct microscopic equilibrium constants Ki 
(corresponding to AGlass) and K2 (corresponding to AG2ass). 
When K1=K2, the scaled fractional saturation function Y of 
the catalyst PrPSc by PrP c corresponds to a Michaelian (i.e. 
non-cooperative) binding isotherm. Conversely, when K\ < K2 
(defined as association constants), PrP c binding is coopera-
tive, i.e. the binding of PrP c to free PrPSc facilitates further 
binding of PrP c to the p rPS c-PrP c complex. 
At the molecular level, cooperativity of the over-all binding 
process depends upon the stability of the subunits ideally iso-
lated relative to the aggregated states, assuming that this proc-
ess does not involve any conformational change [21]. 
2.2. Cooperativity of conformational transitions 
Considering the associated heterotrimer PrPSc-(PrPc)2 in 
Fig. 1, the problem is now: in what ways conformational 
Fig. 1. Uni- and bimolecular catalytic processes involving the PrPSc 
isoform of the prion protein. The binary complex PrPc-PrPSc can 
evolve along two alternative pathways (in addition to the reverse 
dissociation): either isomerization of PrPc subunit into PrPSc iso-
form and subsequent binding of the second PrPc molecule (pathway 
1) or firstly binding of the second PrPc subunit followed by the first 
conversion step of PrPc into PrPSc (pathway 2). Both pathways are 
thermodynamically equivalent. 
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• AGcc (rs. AGscSc) the relative free energy expressing the 
strength of interactions between two subunits in the 
same P r P c (rs. PrPS c) conformation. 
• AGcsc the relative free energy expressing the strength of 
interactions between one subunit in the P r P c conforma-
tion and another subunit in the PrPS c conformation. 
(Strictly speaking, AGcsc expresses the mean free energy 
between the bonding sets a of a PrPS c monomer and b of 
a P r P c monomer on the one hand and the bonding sets 
b of a P r P c monomer and a of a PrS c monomer on the 
other hand). 
Hence, each of the global free energy change AGlc o nv and 
AG2 c o n v in Fig. 1 may be split into the following contribu-
tions : 
Avjt-conv 
l\\jZconv 
; A G t + AGscSc-AGcc 
:AG t +2AG S cS C -2AGcsc 
Positive cooperativity will be observed in the global process 
of conformational change if and only if AG2 c o n v < AGl c o n v , 
i.e.: 
An AGcc+AGscSc 
Thus, positive cooperativity in the conformational process 
will be observed if subunit interactions between P r P c and 
p rpSc m o n o m e r s are destabilizing compared to subunit inter-
actions between monomers in the same conformation. 
Fig. 2. Reaction cycles for the conformational transition between 
normal and pathogenic forms of the prion protein catalyzed by the 
monomeric and dimeric isoform PrPSc. 
AG t the energy difference between free (i.e. dissociated) 
PrPS c and P r P c subunits. 
2.3. Influence of cooperative effects on the rate of 
conformational changes 
Fig. 2 presents the general kinetic scheme corresponding to 
a mechanism in which the dimeric and trimeric complexes are 
active in the conversion process. In order to identify the key 
influences which can govern prion propagation, we shall iso-
late three limiting cases (Fig. 3) from this generic scheme. The 
model of Fig. 3A corresponds to the Prusiner's mechanism of 
unimolecular catalysis. It will be used as a reference. Com-
Fig. 3. Comparison between the catalytic efficiency obtained in three particular models derived from the generic scheme of Fig. 2. A: Linear 
autocatalytic model of Prusiner. Compared to Fig. 3, dissociation of the complex (PrPSc)2 is supposed to occur faster than the putative binding 
of normal free subunit PrP c to form a ternary complex. Moreover, uncatalyzed formation of homodimer p rpS c_p rpS c is neglected. B : Coopera-
tive autocatalytic scheme with preferential interactions between PrP c and PrPSc isoforms. In theses conditions, direct interactions between two 
prpSc free s u b u n i t s c a n be neglected compared to the interactions occurring between PrP c and PrPSc isoforms. C: Cooperative autocatalytic 
scheme with preferential interactions between PrPSc isoforms. In this model, the opposite assumption concerning preferential interactions is con-
sidered: PrPSc is supposed to interact more easily with PrPSc rather than with PrP c . Hence, except at the very beginning of the reaction, cataly-
sis essentially acts through the dimeric form p rpS c_p rpS c 0f the catalyst. In the numerical simulations, arbitrary units of time [t] and concentra-
tion [c] were considered. Hence, we can demonstrate the nature of the system independently of the quantitative values of the parameters (yet 
unknown). Real units that would be given to the rate constants would fix absolute values on the graphical axes. In the three models, according 
to the classical hypothesis of rapid equilibrium in enzyme kinetics, association and dissociation processes are assumed to be fast compared to 
conversions (fcdo = kn =k^a = 1000 [t]~l and fca2 = 1000 [c]_1[/]-1). Hence, global catalyzed steps: 
(PrPSc)i(PrPc)j + P r P c -> ( P r P ^ + ^ P r P 0 ) ; 
may be considered as Michaelian processes with an over-all rate v such as: 
- è S [ ( P t P & ) i ( P ^ 
Finally, since the concentration of the prion protein probably never exceeds several hundred nanomolar, we supposed that Kyi » [PrPc] (this 
assumption allows us to reduce the number of parameters, although the behaviour of the models does not depend on its validity). In these con-
ditions, the global catalyzed steps may be considered as second-order processes with a rate constant k^ = kCB,JKu- As a result of cooperativity, 
dimeric catalysis is assumed to be 100-fold more efficient than monomeric catalysis (£T2 = 100 &TI with fcT1 = 10~4 [c]_1[ï]-1). Each simulation 
was performed by numerical integration of the differential equations governing the time evolution of the corresponding system, with initial con-
ditions such as: [PrPc]0 = 1000 [c], [PrPSc]0 = 1 [c] and the initial concentrations of other complexes equal zero. 
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pared to the general scheme of Fig. 2, the affinity of the 
complex (PrPSc)2 for free PrP c subunits is supposed to be 
very low. Moreover, PrPSc is supposed to bind much more 
easily to PrP c rather than to PrPSc. The second model (Fig. 
3B) assumes that free PrPSc preferentially interacts with PrP c 
subunits. In the third model (Fig. 3C), the opposite hypothesis 
is considered: free PrPSc subunits preferentially bind to PrPSc 
to constitute a catalytic homodimer. 
To characterize the catalytic efficiency in each of these 
schemes, we shall consider, in all numerical simulations, that 
a very low fraction of pathogenic form PrPSc (1/1000 of native 
protein PrPc) is initially present in the medium, as a result of 
the spontaneous conversion. Assuming usual hypotheses of 
enzyme kinetics (see legends of Fig. 3), the rate of each cata-
lyzed step (i) may be treated as a second-order rate law in 
which the rate constant kT^ equals kcat^/KM^. The crucial 
point of this analysis is as follows: what ratio between A?ri 
(catalysis by the monomer PrPSc) and À;T2 (catalysis by the 
A. Linear autocatalysis (Prusiner) 
B. Cooperative autocatalysis with PrP c-PrPS c preferential interactions 
C. Cooperative autocatalysis with PrPSc-PrPSc preferential interactions 
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Fig. 4. Relative importance of the cooperative effect compared to 
that of linear autocatalysis. Starting from identical values of param-
eters and initial concentrations for all the simulations, the relative 
importance of each of these factors may be quantitatively assessed 
from the measure of half-reaction times. Except for fcj2» all other 
values were those of Fig. 3. A: Linear autocatalysis effect. Kinetics 
of conformation changes are compared for a simple exponential 
process (which corresponds to the case where the product of the re-
action does not behave as a catalyst) and the Prusiner's mechanism 
of linear autocatalysis (Fig. 3A). B: Cooperative effect. In each of 
the models of Fig. 3B,C, three distinct simulations have been per-
formed, with different values of the rate constant Â:T2 (which ex-
presses the efficiency of the dimeric catalysis). For a given &T2 value, 
the interval between the curves corresponding to the two models 
has been drawn in a grey scale. Since these models have to be con-
sidered as limiting cases, any intermediary situation would take 
place in the corresponding grey zone. When k-Yi exceeds kn value, 
half-reaction time is greater for model 3B than for model 3C. An 
opposite behaviour is obtained for fci2 = fc-ri (absence of cooperativ-
ity). 
dimer PrPSc-PrPSc) values can rightfully be expected? We saw 
that cooperativity may come from two cumulative, distinct 
origins. In parametric terms, cooperativity in the assembly 
process acts on KM whereas cooperativity resulting from the 
modification of subunit interactions upon conformational 
changes acts on the catalytic constant fccat. When both factors 
are favourable (increase of kclA and decrease of AM), their 
effects are multiplying in fcT. For instance, when each of these 
parameters is improved by a factor 10, the second-order rate 
constant by corresponding to dimeric catalysis is increased by 
a factor 100 compared to catalysis by the monomer PrPSc. 
Such a rate enhancement would be much more difficult to 
expect in classical allosteric systems. 
Fig. 3 shows the benefit, in terms of catalytic efficiency, 
resulting from a cooperative dimeric catalysis compared to 
monomeric catalysis, as it occurs in the Prusiner mechanism. 
Half-time of conversion is decreased by a factor from 10 to 60 
(depending on the model) when dimeric catalysis is assumed 
to be 100-fold more efficient than monomeric catalysis. Yet 
larger amplification factors would be expected for any oligo-
meric complexes having higher order interactions than trimer. 
2.4. Cooperative amplification and linear autocatalysis 
Fig. 4 compares the relative importance, in terms of cata-
lytic efficiency, of cooperative amplification and linear auto-
catalysis (which is present both in cooperative and non-coop-
erative models since it results from the fact that the product of 
the reaction is also a catalyst). All the numerical calculations 
were performed assuming the same initial ratio between the 
concentrations of PrP c and PrPSc isoforms. When linear au-
tocatalysis decreased by a factor 100 the half-time of the re-
action (compared to a simple exponential process, which cor-
responds to the case where the product is not also a catalyst 
of the reaction), an additional effect of a similar amplitude 
may be expected for a cooperative amplificaton factor (&T1/ 
&T2 ratio) of 100. On the contrary, when this ratio does not 
exceed 5, the benefit resulting from the cooperative effect is 
marginal compared to the linear autocatalytic effect. 
When dimeric catalysis is not cooperative (fcri = k-rz), the 
over-all conversion process is slower in the models of multi-
meric catalysis than in the Prusiner model. This results from 
the fact that, at the very beginning of the reaction, increase in 
concentration of the active catalyst is immediate in the mo-
momeric mechanism, whereas it is partially delayed in the 
other models, leading to a longer lag-time period. This para-
doxical effect might have some importance for the under-
standing of the species barrier phenomenon [23-26]. 
2.5. Homo- or hetero-catalytic oligomer? 
From the results above, we can easily anticipate the behav-
iour of a system in which the heterodimer p r p c PrPSc would 
be the effective catalyst, as suggested by Come et al. [15]. 
Although the kinetic scheme would slightly differ from those 
we have analyzed, large cooperative amplification factors 
would be much more difficult to obtain for an heterodimer. 
Since, in such a case, monomeric PrPSc has to be assumed to 
have no catalytic activity (otherwise we find again the schemes 
we have considered above), only the cooperative effect occur-
ring at the assembly steps may be expected. Hence, the bind-
ing of the first PrP c subunit on the PrPSc isoform would have 
to considerably enhance the binding of the second PrP c sub-
unit. Although we cannot rule out such a possibility, it seems 
more improbable, from a thermodynamical viewpoint, than 
that discussed in the case of the homodimer PrPSc-PrPSc. 
3. Discussion 
Thermodynamical considerations show that possible coop-
erative interactions occurring in a multimeric, catalytic assem-
bly of the pathogenic isoform PrPSc of the prion protein, 
could significantly reinforced the autocatalytic character of 
the process of conformational change which is supposed to 
be the fundamental event in prion diseases. Such a strength-
ening is required to explain, according to the Prusiner idea, 
the kinetics of propagation of prion diseases. However, it 
should be noted that an alternative mechanism (the nucleation 
model) of pathogenic prion formation has been proposed [27-
29]. Although this model seems to have similarities to our 
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cooperative model in the sense that it requires assembly of 
PrPSc subunits in a polymeric structure, its thermodynamic 
foundations are quite different [11] because nucleus formation 
corresponds to a series of thermodynamically unfavorable bi-
molecular steps. 
By adding cooperative interactions to the mechanism of 
Prusiner, not only the model can work over a more mean-
ingful range of parameter values but also its dynamic behav-
iour is quite different. As previously shown [12-14], such a 
positive feedback loop endows the system with bistability 
properties, i.e. prion propagation would correspond to a 
switch between a normal and a pathologic, alternative stable 
steady-state. For instance, if we retain the model of Fig. 3C 
and leave the simplifying assumption of a simple second-order 
process, the rate law of conversion between normal and 
pathologic isoforms of the prion protein can be written as : 
:fcs[PrPc] + 
£Cat[PrPc] 
Ku + [PrPC] 
[PrP; Scl2 
in which ks is the first-order rate constant corresponding to 
the spontaneous conversion process. As shown by Kacser and 
Small [14], such a formulation is kinetically equivalent to the 
phenomenological Hill-like equation we previously used 
[12,13] to describe the dynamic properties of the system. 
An important difference between the static view and the 
dynamic one based on the existence of bistability is as fol-
lows: the difficulty in the static mechanism of Prusiner is to 
find realistic values of kinetic parameters such that PrPSc 
would be formed sufficiently slowly by spontaneous conver-
sion to prevent starting of the exponential 'avalanche' of the 
autocatalytic mechanism of infection. On the contrary, it is 
not necessary for the PrPSc isoform concentration to be zero 
in a non-pathogenic cell, in a bistable system. It is sufficient 
for this concentration to remain below a bifurcation threshold 
near the pathogenic steady-state. As a consequence, the rate 
constant corresponding to the spontaneous conversion process 
may be several order of magnitude larger in dynamic condi-
tions than that infered in the case of the explosive model [11]. 
Although much of the experimental evidence supporting the 
'protein only' hypothesis were provided by Prusiner and his 
colleagues, the very concept of a possible 'self-replication' of 
the prion protein was formulated earlier by the late mathema-
tician J.S. Griffith [9]: "Self-replication need not involve any 
very intricate mechanism, provided that suitable components 
are available". Among the components, Griffith emphasized 
the presence of oligomeric forms of the protein. Thirty years 
later, our microscopic and mechanistic thermodynamical con-
siderations agree with Griffith's original proposal. 
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